Connect Biopharma Holdings Ltd (CNTB) stock
CNTBNasdaqPharmaceutical PreparationsFiscal year ends December 31
$0.67+0.09 (+14.93%)
Close on Nov 18, 2026Market cap $41.89MP/E –Yield –
Connect Biopharma revenue
Revenue is the money a company takes in from selling its products and services, before any costs are deducted.
Connect Biopharma's revenue for the twelve months ending Jun 30, 2026 was $2.95M, up 50.3% year over year. For fiscal 2025 it was $64.00K, down 99.8% from the year before.
Annual revenue
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $64.00K | -99.8% |
| FY2024 | Dec 31, 2024 | $26.03M | – |
| FY2023 | Dec 31, 2023 | $0 | – |
Quarterly revenue
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q2 FY2026 | Jun 30, 2026 | $2.77M | +5666.7% |
| Q1 FY2026 | Mar 31, 2026 | $169.00K | – |
| Q4 FY2025 | Dec 31, 2025 | $0 | -100.0% |
| Q3 FY2025 | Sep 30, 2025 | $16.00K | -98.7% |
| Q2 FY2025 | Jun 30, 2025 | $48.00K | -99.8% |
| Q1 FY2025 | Mar 31, 2025 | $0 | – |
| Q4 FY2024 | Dec 31, 2024 | $698.00K | – |
| Q3 FY2024 | Sep 30, 2024 | $1.22M | – |
| Q2 FY2024 | Jun 30, 2024 | $24.12M | – |
See a number that looks wrong?